Harte Hanks, Inc.
US ˙ NasdaqGM ˙ US4161962026

SecurityHHS / Harte Hanks, Inc.
InsiderDavid L Copeland
This page shows the track record and history of COPELAND DAVID L insider trades in Harte Hanks, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by David L Copeland in HHS / Harte Hanks, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Max		 Price at
Max		 Max
Profit ($)		 Max Return (%)
2022-02-28 15,000 6.5600 15,000 6.5600 98,400 176 17.6500 166,350 169.05
2012-08-14 12,892 6.6317 1,289 66.3170 85,496
2012-08-13 7,108 6.5534 711 65.5340 46,582

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

HHS / Harte Hanks, Inc. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by David L Copeland in HHS / Harte Hanks, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Min		 Price at
Min		 Max Loss
Avoided ($)		 Max Loss
Avoided (%)
2021-11-16 17,182 8.0600 17,182 8.0600 138,487 10 8.0000 -1,030 -0.74
2007-02-22 2,000 27.5700 200 275.7000 55,140

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

HHS / Harte Hanks, Inc. Insider Trades
Insider Transaction History
File
Date		 Trade
Date		 Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price		 Unit
Price		 Units
Changed		 Value
Changed (1K)		 Remaining
Options		 Remaining
Shares
2023-08-21 2023-08-17 4 COPELAND DAVID L HHS Common Stock A - Award D 5.5500 16,216 90 110,337
2022-03-17 2022-03-16 4 COPELAND DAVID L HHS Common Stock A - Award D 7.1400 12,605 90 94,121
2022-02-28 2022-02-28 4 COPELAND DAVID L HHS Common Stock P - Purchase D 6.5600 15,000 98 81,516
2021-11-18 2021-11-16 4/A COPELAND DAVID L HRTH Common Stock S - Sale D 8.0600 -17,182 -138 66,516
2021-11-16 2021-11-16 4 COPELAND DAVID L HRTH Common Stock S - Sale D 8.0600 -17,182 -138 407,722
2021-08-18 2021-08-17 4 COPELAND DAVID L HRTH Common Stock A - Award D 13,678 424,904
2020-09-01 2020-08-08 4 COPELAND DAVID L HRTH Common Stock A - Award D 18,000 70,020
2020-09-01 2020-07-27 4 COPELAND DAVID L HRTH Restricted Stock Units M - Exercise D -2,278 2,279
2020-09-01 2020-07-27 4 COPELAND DAVID L HRTH Common Stock M - Exercise D 2,278 49,741
2020-09-01 2020-06-23 4 COPELAND DAVID L HRTH Restricted Stock Units M - Exercise D -2,062 0
2020-09-01 2020-06-23 4 COPELAND DAVID L HRTH Common Stock M - Exercise D 2,062 47,463
2020-09-01 2020-03-21 4 COPELAND DAVID L HRTH Restricted Stock Units M - Exercise D -23,136 0
2020-09-01 2020-03-21 4 COPELAND DAVID L HRTH Common Stock M - Exercise D 23,136 45,401
2019-09-05 2019-07-27 4 COPELAND DAVID L HHS Restricted Stock Units M - Exercise D -2,278 4,557
2019-09-05 2019-07-27 4 COPELAND DAVID L HHS Common Stock M - Exercise D 2,278 22,265
2019-06-24 2019-06-23 4 COPELAND DAVID L HHS Restricted Stock Units M - Exercise D -2,062 2,062
2019-06-24 2019-06-23 4 COPELAND DAVID L HHS Common Stock M - Exercise D 2,062 20,730
2019-03-28 2019-03-21 4 COPELAND DAVID L HHS Common Stock A - Award D 23,136 52,020
2018-07-30 2018-07-27 4 COPELAND DAVID L HHS Common Stock A - Award D 6,835 28,885
2018-06-25 2018-06-23 4 COPELAND DAVID L HHS Restricted Stock Units M - Exercise D -2,061 4,124
2018-06-25 2018-06-23 4 COPELAND DAVID L HHS Common Stock M - Exercise D 2,061 17,926
2017-06-27 2017-06-23 4 COPELAND DAVID L HHS Restricted Stock Units A - Award D 61,855 61,855
2016-04-18 2016-04-15 4 COPELAND DAVID L HHS Common Stock A - Award D 22,304 158,661
2015-02-09 2015-02-05 4 COPELAND DAVID L HHS Common Stock A - Award D 7,731 136,357
2014-02-06 2014-02-05 4 COPELAND DAVID L HHS Common Stock A - Award D 8,559 128,626
2013-02-06 2013-02-05 4 COPELAND DAVID L HHS Common Stock A - Award D 6,476 120,067
2012-08-15 2012-08-14 4 COPELAND DAVID L HHS Common Stock P - Purchase D 6.6317 12,892 85 113,591
2012-08-15 2012-08-13 4 COPELAND DAVID L HHS Common Stock P - Purchase D 6.5534 7,108 47 100,699
2012-02-06 2012-02-05 4 COPELAND DAVID L HHS Common Stock A - Award D 5,045 93,591
2007-04-06 2007-02-22 4 COPELAND DAVID L Custodian HHS Common Stock S - Sale I 27.5700 -2,000 -55 5,650
2006-01-30 2006-01-26 4 COPELAND DAVID L HHS Common Stock A - Award D 1,937 66,944
2004-09-08 2004-05-18 4 COPELAND DAVID L HHS Stock Option (right to buy) A - Award D 23.10 4,200 4,200
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)